Personal information

Activities

Employment (1)

University of North Carolina at Chapel Hill: Chapel Hill, NC, US

1993-07-23 to 2015-08-11 | Elizabeth Thomas Professor of Medicine, Microbiology and Immunology (Internal Medicine)
Employment
Source: Self-asserted source
Jonathan Serody

Education and qualifications (2)

University of Virginia School of Medicine: Charlottesville, VA, US

1982-08-20 to 1986-05-13 | MD (Medicine)
Education
Source: Self-asserted source
Jonathan Serody

University of Virginia: Charlottesville, Virginia, US

1978-08-21 to 1982-05-12 | BA (Biology)
Education
Source: Self-asserted source
Jonathan Serody

Funding (10)

Targeting CCR7 for the Prevention/Treatment of GvHD

2012-07-02 to 2016-05-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
GRANT_NUMBER: 5R01HL115761-04
GRANT_NUMBER: 5R01HL115761-04
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Th1/Th17 Macrophage Interactions in Cutaneous GVHD

2012-05-09 to 2017-03-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R01CA166794-04
GRANT_NUMBER: 5R01CA166794-04
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Modeling TH17 Cells in Acute GVHD

2010-09-01 to 2011-08-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1R56AI084219-01A1
GRANT_NUMBER: 1R56AI084219-01A1
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Multimodality Therapy for Metastatic Breast Cancer

2005-04-15 to 2008-03-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R21CA105837-02
GRANT_NUMBER: 5R21CA105837-02
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Treg Migration in GVHD

2005-04-01 to 2012-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 2R56AI064363-06A1
GRANT_NUMBER: 2R56AI064363-06A1
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Treg Migration in GVHD

2005-04-01 to 2010-12-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R01AI064363-05
GRANT_NUMBER: 5R01AI064363-05
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Mechanisms Involved in T cell trafficking in GVHD

2003-08-01 to 2010-05-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R01CA102052-05
GRANT_NUMBER: 5R01CA102052-05
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

IMMUNOTHERAPY FOR METASTATIC BREAST CANCER

2000-09-30 to 2002-09-29 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R21CA089961-02
GRANT_NUMBER: 5R21CA089961-02
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

ID OF EPITOPES FROM CML RECOGNIZED BY T CELLS

1996-05-01 to 2001-04-30 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5K08CA066715-05
GRANT_NUMBER: 5K08CA066715-05
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

CLONING AND REGULATION OF A LACTOFERRIN RECEPTOR GENE

1992-03-29 to present | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1F32AI008409-01A1
GRANT_NUMBER: 1F32AI008409-01A1
Source: Self-asserted source
Jonathan Serody via DimensionsWizard

Peer review (7 reviews for 4 publications/grants)

Review activity for Cancer cell. (2)
Review activity for Cell. (2)
Review activity for Nature biomedical engineering. (1)
Review activity for Nature communications (2)